These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 36627305)

  • 21. An Unexpected Major Role for Proteasome-Catalyzed Peptide Splicing in Generation of T Cell Epitopes: Is There Relevance for Vaccine Development?
    Platteel ACM; Liepe J; van Eden W; Mishto M; Sijts AJAM
    Front Immunol; 2017; 8():1441. PubMed ID: 29163514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peptide splicing by the proteasome.
    Vigneron N; Ferrari V; Stroobant V; Abi Habib J; Van den Eynde BJ
    J Biol Chem; 2017 Dec; 292(51):21170-21179. PubMed ID: 29109146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteolysis and class I major histocompatibility complex antigen presentation.
    York IA; Goldberg AL; Mo XY; Rock KL
    Immunol Rev; 1999 Dec; 172():49-66. PubMed ID: 10631936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New Insights into the Mechanisms of Proteasome-Mediated Peptide Splicing Learned from Comparing Splicing Efficiency by Different Proteasome Subtypes.
    Ferrari V; Stroobant V; Abi Habib J; Naulaerts S; Van den Eynde BJ; Vigneron N
    J Immunol; 2022 Jun; 208(12):2817-2828. PubMed ID: 35688464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characteristics of HIV-1 Nef regions containing multiple CD8+ T cell epitopes: wealth of HLA-binding motifs and sensitivity to proteasome degradation.
    Choppin J; Cohen W; Bianco A; Briand JP; Connan F; Dalod M; Guillet JG
    J Immunol; 2001 May; 166(10):6164-9. PubMed ID: 11342637
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differences in the production of spliced antigenic peptides by the standard proteasome and the immunoproteasome.
    Dalet A; Stroobant V; Vigneron N; Van den Eynde BJ
    Eur J Immunol; 2011 Jan; 41(1):39-46. PubMed ID: 21182075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Database search engines and target database features impinge upon the identification of post-translationally cis-spliced peptides in HLA class I immunopeptidomes.
    Mishto M; Horokhovskyi Y; Cormican JA; Yang X; Lynham S; Urlaub H; Liepe J
    Proteomics; 2022 May; 22(10):e2100226. PubMed ID: 35184383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Invariant chain as a vehicle to load antigenic peptides on human MHC class I for cytotoxic T-cell activation.
    Wälchli S; Kumari S; Fallang LE; Sand KM; Yang W; Landsverk OJ; Bakke O; Olweus J; Gregers TF
    Eur J Immunol; 2014 Mar; 44(3):774-84. PubMed ID: 24293164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Definition of Proteasomal Peptide Splicing Rules for High-Efficiency Spliced Peptide Presentation by MHC Class I Molecules.
    Berkers CR; de Jong A; Schuurman KG; Linnemann C; Meiring HD; Janssen L; Neefjes JJ; Schumacher TN; Rodenko B; Ovaa H
    J Immunol; 2015 Nov; 195(9):4085-95. PubMed ID: 26401003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Splicing of distant peptide fragments occurs in the proteasome by transpeptidation and produces the spliced antigenic peptide derived from fibroblast growth factor-5.
    Dalet A; Vigneron N; Stroobant V; Hanada K; Van den Eynde BJ
    J Immunol; 2010 Mar; 184(6):3016-24. PubMed ID: 20154207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Shuffling peptides to create T-cell epitopes: does the immune system play cards?
    Mannering SI; So M; Elso CM; Kay TWH
    Immunol Cell Biol; 2018 Jan; 96(1):34-40. PubMed ID: 29359347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Perpetual complexity: predicting human CD8
    Di Carluccio AR; Triffon CF; Chen W
    Immunol Cell Biol; 2018 Apr; 96(4):358-369. PubMed ID: 29424002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple proteases process viral antigens for presentation by MHC class I molecules to CD8(+) T lymphocytes.
    Del-Val M; López D
    Mol Immunol; 2002 Oct; 39(3-4):235-47. PubMed ID: 12200053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Driving forces of proteasome-catalyzed peptide splicing in yeast and humans.
    Mishto M; Goede A; Taube KT; Keller C; Janek K; Henklein P; Niewienda A; Kloss A; Gohlke S; Dahlmann B; Enenkel C; Kloetzel PM
    Mol Cell Proteomics; 2012 Oct; 11(10):1008-23. PubMed ID: 22822185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estimating the Contribution of Proteasomal Spliced Peptides to the HLA-I Ligandome.
    Mylonas R; Beer I; Iseli C; Chong C; Pak HS; Gfeller D; Coukos G; Xenarios I; Müller M; Bassani-Sternberg M
    Mol Cell Proteomics; 2018 Dec; 17(12):2347-2357. PubMed ID: 30171158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Large-Scale Immunopeptidome Analysis Reveals Recurrent Posttranslational Splicing of Cancer- and Immune-Associated Genes.
    Levy R; Alter Regev T; Paes W; Gumpert N; Cohen Shvefel S; Bartok O; Dayan-Rubinov M; Alon M; Shmueli MD; Levin Y; Merbl Y; Ternette N; Samuels Y
    Mol Cell Proteomics; 2023 Apr; 22(4):100519. PubMed ID: 36828127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generating MHC class I ligands from viral gene products.
    Yewdell J; Antón LC; Bacik I; Schubert U; Snyder HL; Bennink JR
    Immunol Rev; 1999 Dec; 172():97-108. PubMed ID: 10631940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differences in the expression of human class I MHC alleles and their associated peptides in the presence of proteasome inhibitors.
    Luckey CJ; Marto JA; Partridge M; Hall E; White FM; Lippolis JD; Shabanowitz J; Hunt DF; Engelhard VH
    J Immunol; 2001 Aug; 167(3):1212-21. PubMed ID: 11466336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neo-Splicetopes in Tumor Therapy: A Lost Case?
    Kloetzel PM
    Front Immunol; 2022; 13():849863. PubMed ID: 35265089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peptide Splicing in the Proteasome Creates a Novel Type of Antigen with an Isopeptide Linkage.
    Berkers CR; de Jong A; Schuurman KG; Linnemann C; Geenevasen JA; Schumacher TN; Rodenko B; Ovaa H
    J Immunol; 2015 Nov; 195(9):4075-84. PubMed ID: 26401000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.